Meridian to market E coli rapid test in US:
This article was originally published in Clinica
Meridian Diagnostics will market its ImmunocardStat! E coli 0157 Plus rapid test in the US. The test determines whether E Coli is the cause of gastroenteric-related disease in ten minutes. The Cincinnati, Ohio-based company claims prompt diagnosis of the infection can reduce healthcare costs, by preventing acute renal failure and haemolytic uraemic syndrome, brought on by the toxins generated by the bacterium.
You may also be interested in...
ConMed Corp. is company of two halves ̶ general surgery and orthopedics – and is readying itself for a renewed assault on these two markets on the back of a technology pipeline, targeted acquisitions and a new growth-winning culture, says CFO Todd Garner.
Drug pricing and access issues expose the pharmaceutical sector especially acutely to calls for companies to meet ethical and social goals, alongside commercial ones. Digital is up-ending pharma’s processes, its workplaces and its consumers. R&D productivity is spluttering. Amid this turmoil, CEOs highlight company culture – the way an organization behaves – as a crucial ingredient for success. But what is a “right” culture? Organizational culture is neither static nor singular. It is continuously influenced by acquisitions, markets, new technologies and new generations. And pharma’s history suggests that culture change cannot happen without sufficient people change.